Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Association of High-sensitivity C-reactive Protein to Albumin Ratio with Metabolic Dysfunction-associated Fatty Liver Disease and Liver Fibrosis: a Cross-sectional Study

NCT05974904 is registered in ClinicalTrials.gov with Chongqing Medical University as lead sponsor.

NCT NCT05974904
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05974904 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Association of High-sensitivity C-reactive Protein to Albumin Ratio with Metabolic Dysfunction-associated Fatty Liver Disease and Liver Fibrosis: a Cross-sectional Study
Lead sponsor
Chongqing Medical University
Phase
Observational
Overall status
Recruiting
Start date
July 18, 2023
Completion date
December 28, 2026
Enrollment
7,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatic steatosis, liver fibrosis, metabolic dysfunction-associated fatty liver disease